Thus, patients receiving a dose of 100 × 106 allogeneic MSCs showed better outcomes in endothelial function and in the reduction of levels of the proinflammatory cytokine, tumor necrosis factor-alpha (TNF-α), usually increased in heart disease. The gene discussed is TNF; the disease is heart disorder.